Acquisition Announced

Sun Pharmaceutical Industries acquisition of Organon & Co.

US$12bn enterprise value

Announced 26 Apr 2026 · NYSE: OGN · US$14.00 cash per share

Advisers

Organon & Co.

Target

Financial adviser
Fairness opinion

Sun Pharmaceutical Industries

Acquirer

Financial adviser
Target
Organon & Co.
Acquirer
Sun Pharmaceutical Industries
Target based in
United States
Buyer based in
India
Sector
Pharma

In the league tables

Similar deals

All pharma deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.